Policy: Division Head Transfusion Medicine Role in Policy Making

Principle:

The Division Head, Transfusion Medicine and Blood Banks, is responsible for all aspects of transfusion medicine at HMC for the State of Qatar.  The following policy documents some of those roles.

Policy:

  1. The Division Head, Transfusion Medicine HTM, serves as a member of the Corporate Transfusion Committee
  2. The HTM through the CTC establishes criteria for transfusion of blood components and passes these through the HMC corporate process for establishing official guidelines.
  3. The HTM reviews blood component requests, especially in times of shortage to triage in conjunction with the Medical Director and Chairperson, DPLM
  4. The HTM establishes transfusion practices through the interim policies, which are in turn used to prepare processes and procedures through corporate transfusion medicine.
  5. The HTM serves as Project Manager for the Medinfo Hematos IIG computer system and prepares policies, processes, and procedures for Transfusion Laboratory Information Systems.

References:

Standards for Blood Banks and Transfusion Services, Current Edition AABB, Bethesda, MD, USA

Process: Interdepot Transfer

Enumeration:  5.9.1

Process:

  1. All transfers of blood components will be done through the dedicated blood bank computer system Medinfo Hematos IIG.
  2. Ensure that the final ISBT label is attached.
  3. Each unit must have a final ISBT label attached.
  4. Prepare a consignment list for the units to be transferred.
  5. Transfer the units in temperature controlled and monitored, validated containers.
  6. Upon receipt at the destination, check the temperature log or liquid crystal sticker to confirm the unit(s) have been maintained at the proper temperature.
  7. Upon receipt at the destination, repeat the ABO forward and D type of the transferred RBC units and the reverse type of the plasma units.
  8. Subsequent transfers between hospital blood banks do not require repeat ABO/D typings.
  9. Inspect each unit for leaks and physical appearance (e.g. clots, leaks, discoloration).
  10. Enter the new stock into the local hospital’s inventory.
  11. Use the specific transfer algorithms programmed into the Medinfo Hematos IIG software.
  12. All variances will be reviewed by the supervisor and a transfusion medicine physician.

References:

  1. HMC 1001 Setting Specification, Version 1.5, Hematos IIG, Medinfo
  2. Standards for Blood Banks and Transfusion Services, Current Edition, AABB, Bethesda, Maryland, USA

Policy: Interdepot Transfer

Enumeration:  5.9

Policy:

  1. All transfers of blood components will be done through the dedicated blood bank computer system Medinfo Hematos IIG.
  2. Only units passing all donation criteria including testing and processing will be eligible for transfer.
  3. Each unit must have a final ISBT label attached.
  4. Quarantined units will be discarded through Medinfo at the blood processing site.
  5. Units will be transferred in temperature controlled and monitored, validated containers.
  6. Upon receipt, the ABO forward and D type of the transferred RBC units will be repeated at the first hospital blood bank.
  7. Subsequent transfers between hospital blood banks do not require repeat ABO/D typings.
  8. Each unit will be inspected for leaks and physical appearance (e.g. clots, leaks, discoloration).
  9. Only units whose temperature monitoring passes criteria for transit shall be used.
  10. The specific transfer algorithms will be programmed into the Hematos IIG software.
  11. All variances will be reviewed by the supervisor and a transfusion medicine physician.
  12. All policies, processes, and procedures must comply with Qatari, HMC, and applicable accreditation standards (i.e. AABB, CAP, and JCI).

References:

  1. HMC 1001 Setting Specification, Version 1.5, Hematos IIG, Medinfo
  2. Standards for Blood Banks and Transfusion Services, Current Edition, AABB, Bethesda, Maryland, USA

Policy: Component Processing

Enumeration:  5.8

Policy:

  1. All processing will be in accordance with good manufacturing practices.
  2. All testing will follow manufacturer’s recommended testing methods.
  3. The specific processing algorithms will be programmed into the Hematos IIG software.
  4. Validation of the processing will be performed by Hematos IIG, which will control final ISBT labelling
  5. All abnormal results will be reviewed by a transfusion medicine physician.
  6. All policies, processes, and procedures must comply with Qatari, HMC, and applicable accreditation standards (i.e. AABB, CAP, and JCI).

References:

  1. HMC 1001 Setting Specification, Version 1.5, Hematos IIG, Medinfo
  2. Standards for Blood Banks and Transfusion Services, Current Edition, AABB, Bethesda, Maryland, USA